A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome

Clinical trial NCT06722079 · COMPLETED

Trial details

NCT number: NCT06722079
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Turner Syndrome

Start date: 2022-11-08
Primary completion: 2023-06-05
Enrollment: 743

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.